Sharon M Weber, MD, FACS

Professor

  • Chair, Division of Surgical Oncology
  • Medical Director of Surgical Oncology, UW Carbone Cancer Center
  • Endowed Professor, Tim and Mary Ann McKenzie Professorship in Surgical Oncology

webers@surgery.wisc.edu
(608) 262-2025

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Clinical Science Center
Madison, Wisconsin 53792-7375

Education

  • MD, University of Wisconsin Medical School, Madison, WI
  • Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI
  • Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY
  • Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY

Clinical Specialties

Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.

Research Interests

Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors. Dr. Weber’s research interests also include mixed methods evaluation of risk factors for readmission using a systems engineering approach with a focus on the transition of care and outcomes research evaluating preoperative predictors of postoperative complications.

Recent Publications

  • Beyond borders: insights from the Society of Surgery for the Alimentary Tract Junior Surgeon Travel Exchange Program.
    Szor DJ, Zafar SN, Weber S, Ribeiro U
    J Gastrointest Surg 2024 Jun; 28(6): 993-994
    [PubMed ID: 38579931]

  • Preoperative anemia: impact on short- and long-term outcomes following curative-intent resection of gastroenteropancreatic neuroendocrine tumors.
    Xiang JX, Nan YL, He J, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM
    J Gastrointest Surg 2024 Jun; 28(6): 852-859
    [PubMed ID: 38538480]

  • ASO Visual Abstract: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors-A Multi-Institutional Study.
    Zhang N, He J, Maithel SK, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Lv Y, Zhang XF, Pawlik TM
    Ann Surg Oncol 2024 Jan 15;
    [PubMed ID: 38225473]

  • Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
    Zhang N, He J, Maithel SK, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Lv Y, Zhang XF, Pawlik TM
    Ann Surg Oncol 2024 May; 31(5): 2882-2891
    [PubMed ID: 38097878]

  • ASO Visual Abstract: Association of Neighborhood Disadvantage with Short- and Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
    Marcinak CT, Praska CE, Vidri RJ, Taylor AK, Krebsbach JK, Ahmed KS, LoConte NK, Varley PR, Afshar M, Weber SM, Abbott DE, Mathew J, Murtaza M, Burkard ME, Churpek MM, Zafar SN
    Ann Surg Oncol 2024 Jan; 31(1): 552-553
    [PubMed ID: 37805945]

All Publications on PubMed